Long‐term assessment of neuropsychiatric adverse reactions associated with efavirenz

Pierre Lochet,Hélène Peyrière,A. Lotthé,J. Mauboussin,B. Delmas,Jacques Reynes
DOI: https://doi.org/10.1046/j.1468-1293.2003.00136.x
2003-01-01
HIV Medicine
Abstract:The Sensio study objectives were to assess the outcome of neuropsychiatric adverse reactions (NPAR) that develop after initiation of efavirenz (EFV) therapy, to ascertain the late NPAR after a 3‐month treatment period, to evaluate the impact of NPAR on patients' quality of life (QoL) in a real‐life population.
What problem does this paper attempt to address?